Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery. Its cell replacement platform creates new cells and tissues with its pluripotent and progenitor cell technologies. The company's cell and drug delivery programs are based upon its proprietary HyStem cell and drug delivery matrix technology. It engages in the research and development of regenerative medicine or therapeutic products for advancement in the field of oncology, orthopedics, retinal and neurological diseases and disorders, blood and vascular system diseases and disorders, blood plasma volume expansion, diagnostic products for the early detection of cancer and hydrogel products that may be used in surgery and products for human embryonic stem cell research. The company was founded by Judith Segall, Hal Sternberg, Paul E. Segall and Harold D. Waitz on November 30, 1990 and is headquartered in Carlsbad, CA.

Board of Trustees of Michigan State University, part of Michigan State University, is an American company that trusts Except Educational Religious.

DH Technologies Development Pte Ltd. engages in holding or owning of companies. The company was founded on August 3, 2009 and is headquartered in Singapore.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud, and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

Dimension Therapeutics is a gene therapy company focused on developing novel treatments for rare diseases. Their team comprises biotech industry veterans and thought leaders in gene therapy and rare diseases. The company is focused on advancing its platform of gene therapy programs in rare diseases through clinical development, starting with lead programs in hemophilia, and building out a world-class product engine for adeno-associated virus (AAV) therapeutics. In conjunction with its launch, Dimension has entered into an exclusive license and collaboration with REGENX Biosciences. REGENX holds exclusive rights to a portfolio of over 100 patents and patent applications pertaining to its NAV vector technology and related applications. Through its license and collaboration with REGENX, Dimension has acquired preferred access to NAV vector technology and rights within REGENX product programs in multiple rare disease indications. Dimension has completed a Series A financing led by Fidelity Biosciences.

BGI Tech Solutions Co., Ltd. (BGI-Tech), is a world leader in cutting-edge life sciences technology and premier scientific partner to the global research community. With a firm commitment to providing the highest quality services through our worldwide service network, BGI-Tech’s mission is to facilitate ground-breaking research, foster productive collaboration and accelerate scientific advancement. BGI-Tech was founded in 2012 and is headquartered in Shenzhen, China. BGI-Tech has lab facilities in Hong Kong, Wuhan (China),and Sacramento, California (United States). It also has branch offices in Europe, the Americas, Asia- Pacific, and in Beijing, Shanghai, and Guangzhou of mainland China. Its service network covers more than 100 countries and regions. Currently, BGI-Tech collaborates with over 10,000 organizations and 30,000 partners, providing highly reliable services for thousands of research projects, including several large-scale international genome projects. With diverse service experience, unique scientific expertise, BGI-Tech is committed to developing integrated omics platforms to revolutionize life science research, to accelerate the advancement of the life science industry and to address various health, agricultural, energy, and environmental issues to improve life and society.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Quantum Digital Solutions is an applied sciences firm, is a premier developer of digital Communications, Multimedia Content, Cyber, and Cloud security solutions, absent network isolation. QDSC’s breakthrough in applied cryptography, called the Cypher Linked Exchange System (CypherLXS), delivers the first scalable, low cost quantum-proof key distribution security technology. QDSC’s CypherLXS Network Exchange (CNX) solution is a network provisioned key-management utility. The CNX is capable of addressing the complex free-form permutation - billions of users/systems/devices by millions of points of control by billions of files and communications sessions - confronting Enterprise, SMB, and Consumer class customers exercising network centric applications.

Tiangen Biochemical Technology (Beijing) Co., Ltd., established on 2005-07-19, Business scope includes technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;Research and development of biological reagents;Manufacturing of experimental analysis instruments;Production of Class I medical devices;Sales of medical devices(onlyI,IIkind),Instrumentation,biological reagent,electronic product,Equipment;software development;Computer System Services;commission agent(except auction);Import and export,Agent import and export;production of biological reagents;Production of the second class,Class III medical devices;Sales of Class III Medical Devices.(Enterprises independently choose operating projects according to law,Carry out business activities;Production of the second class,Class III medical devices,Sales of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Junshi Biotechnology (Shanghai) Co., Ltd., established on 2006-03-03, Business scope includes technology development in the field of biotechnology and medical device technology,technical consulting,technology transfer,Technical Services,Production of Medical Devices,medical instruments,Computer software and auxiliary equipment,Laboratory equipment,Sales of mechanical equipment and spare parts,computer software development,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Shanghai Puen Haihui Medical Laboratory Co., Ltd., established on 2017-01-19, Business scope includes general items:medical service,Engaged in technology development in the field of medical science and technology,technical consulting,technology transfer,Technical Services,Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval),Specialty Chemicals Sales,Health Consulting Services(Does not include medical services),Medical Research and Experimental Development,Standardized service.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Silicon Biosystems s.p.a. develops lab-on-a-chip technologies for miniaturized cell-biology testing. Its products include SmartSlide, a disposable Lab-on-a-chip, which works on liquid samples for various tasks, such as enrichment, label-free separation, mating of cells, and/or microbeads; and DEPArray, a cell microarray implementing a technology for individual cell manipulation and detection. The company’s technology is used for cell sorting and cell-cell interaction applications. Silicon Biosystems is based in Bologna, Italy.

Shanghai Tianhao Biotechnology Co., Ltd., established on 2008-04-28, Business scope includes biological reagents(In addition to drugs,dangerous goods),R & D and sales of instruments and meters,Technology development within the specialized field of biotechnology,technology transfer,technical consulting,Technical Services. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Daegu Gyeongbuk Institute of Science and Technology (DGIST) (In Korean 대구경북과학기술원) is a public science and engineering university located in Daegu Metropolitan City, Republic of Korea. Under a Special Act on Support of Scientists and Engineers for Strengthening National Science and Technology Competitiveness, the Korean government enacted Daegu Gyeongbuk Institute of Science and Technology Act (Act No. 6996) and founded DGIST in 2004 as a research institute. In 2008, the act was amended to extend the role of the institute to both research and education, which eventually enabled a transition from a research institute to a university.

Hangzhou Baiyi Technology Co., Ltd., established on 2020-03-02, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Chemical product sales(No licensed chemical products);Wholesale of computer software, hardware and auxiliary equipment;Instrument sales;Communication equipment sales;Disinfectant sales(Free of Hazardous Chemicals);Rubber Products Sales;Sales of plastic products;Electrical Equipment Sales;Information Technology Consulting Services;software sales;software development;Biochemical product technology research and development;Sales of bio-based materials;Specialty Chemicals Sales(Free of Hazardous Chemicals)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

International Business Machines (China) Co., Ltd., established on 2000-12-22, Business scope includes licensed projects:Import and export;career brokerage.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Provide investment and operation decision-making for the enterprises under its jurisdiction,Marketing Services,Staff training and management;Research,to develop,Sales of information technology products,And provide maintenance of related products,After-sales service,Technical service and logistics service;Provide information technology consulting services, business consulting services and related training services;Provide information system and network system design,System Integration and Redundancy Services;Set up customer technical support service center,Provide e-commerce technology,ITOutsourcing services such as outsourcing services and business processes;engage inIBMWholesale business and import and export business of products and similar products;Design and Construction of Building Intelligent System Engineering;Domestic repurchase of self-produced products and similar products produced by third parties,Remanufacturing and Sales(Remanufacturing Limited International Business Machines(China)Co., Ltd. Shenzhen Baoan Branch and Deqing Branch);Remanufacturing and sales of imported old mechanical and electrical products(Except for products in the list of used mechanical and electrical products that are prohibited from being imported)(International Business Machines(China)Co., Ltd. Deqing Branch);Engaged in technology import and export business(Technology imports and exports prohibited by the state or involving administrative approval are excluded);daily mask(non-medical)Production(International Business Machines(China)Co., Ltd. Deqing Branch);HR Services(Excludes job brokerage activities,Labor dispatch service).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Hefei Yuanzai Biotechnology Co., Ltd., established on 2019-04-11, Business scope includes technology promotion in the field of life sciences,technical consulting,Technical service and technology transfer;Experimental instruments and supporting consumables,Electronic product development,Sales and Leasing;Biological reagent production,Sales;Information technology services and software services;Gene big data collection,Storage and analysis and mining related products and technical services;Pre-packaged food,bulk food,dairy products,nutritional supplements,Healthy food,cosmetic,Cleaning Products,Furniture Care Products,Down products,bed linings,craft sales;Domestic advertising design,make,release,acting;daily necessities,Office Supplies,clothing,Baby Products,Stationery,vegetable,Dried and Fresh Fruits,wine,drinks,Sales of grain and oil products(Including online sales);Sales of solid beverages and ready-mixed powder;baked goods,instant food,nutritious food,Feed additives,starch,Sales of modified starch;Food Safety Testing Service;Self-operation and agency of various goods or technology import and export business(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Exact Sciences is a molecular diagnostics company focused on colorectal cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Stool-based DNA (sDNA) technology is included in the colorectal cancer screening guidelines of the American Cancer Society and the U.S. Multi-Society Task Force on Colorectal Cancer.